Clinical Trial Update: To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A completed Phase 3 extension study evaluating the efficacy and safety of tocilizumab in adults with moderate to severe rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED